TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Dermacell AB
Closing information (x1000 EUR)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
344
|
286
|
270 |
| Financial expenses |
2
|
0
|
1 |
| Earnings before taxes |
5
|
-15
|
1 |
| EBITDA |
10
|
-11
|
6 |
| Total assets |
91
|
61
|
71 |
| Current assets |
90
|
56
|
62 |
| Current liabilities |
58
|
22
|
12 |
| Equity capital |
18
|
39
|
54 |
| - share capital |
4
|
4
|
5 |
| Employees (average) |
5
|
5
|
4 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
19.8%
|
63.9%
|
76.1% |
| Turnover per employee |
69
|
57
|
68 |
| Profit as a percentage of turnover |
1.5%
|
-5.2%
|
0.4% |
| Return on assets (ROA) |
7.7%
|
-24.6%
|
2.8% |
| Current ratio |
155.2%
|
254.5%
|
516.7% |
| Return on equity (ROE) |
27.8%
|
-38.5%
|
1.9% |
| Change turnover |
53
|
30
|
35 |
| Change turnover % |
18%
|
12%
|
15% |
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % |
0%
|
25%
|
0% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.